How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

I tested a dozen backpacks that work as a personal travel item on airlines to find the best, most durable options to save you from getting dinged by gate fees I travel 200,000 miles a year. This is ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Elissa Sanci Elissa Sanci is a senior writer who has reported on label makers, ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...